Blaine Y Brower

Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer

E. Wallen, M. Harrison, M. Milowsky, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer

E. Basch, M. Milowsky, Y. Whang, 2021, PloS one.

Phase II study of gemcitabine and split-dose cisplatin plus pembrolizumab as neoadjuvant therapy prior to radical cystectomy (RC) in patients with muscle-invasive bladder cancer (MIBC).

E. Wallen, M. Harrison, M. Milowsky, 2021 .

Enfortumab Vedotin: Nursing Perspectives on the Management of Adverse Events in Patients With Locally Advanced or Metastatic Urothelial Carcinoma.

Blaine Y Brower, A. Pace, Dawn Conway, 2021, Clinical journal of oncology nursing.

Fibroblast growth factor receptor status and response to immune checkpoint inhibition in metastatic urothelial cancer.

G. Mayhew, M. Milowsky, William Y. Kim, 2019, Journal of Clinical Oncology.

Managing potential adverse events during treatment with enfortumab vedotin + pembrolizumab in patients with advanced urothelial cancer

V. Koshkin, Blaine Y Brower, J. Rembisz, 2024, Frontiers in oncology.